Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|July 13, 2021
Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinomaChao Wang, Min Shi, Lei Zhang, et al.
Journal for Immunotherapy of Cancer|June 18, 2021
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancerLibin Zhang, Yanhui Chen, Han Wang, et al.
European Journal of Immunology|October 25, 2013
Expansion of activated regulatory T cells by myeloid-specific chemokines via an alternative pathway in CSF of bacterial meningitis patientsGuangzhi Shi, Junyan Han, Gang Liu, et al.
Journal of Translational Medicine|January 19, 2024
Immunogram defines four cancer-immunity cycle phenotypes with distinct clonal selection patterns across solid tumorsYing Hu, Huaibo Sun, Wei Shi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 17, 2026
Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagyHenghui Zhang, Dongqing Li, Mingqiang Su, et al.
Frontiers in Oncology|March 8, 2021
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint InhibitorsYipeng Song, Jian Huang, Dandan Liang, et al.
BMC Infectious Diseases|August 12, 2020
The reduction in CD8<sup>+</sup>PD-1<sup>+</sup> T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patientsRuyu Liu, Yanhui Chen, Jiang Guo, et al.
Cancer Medicine|February 5, 2020
Characterization of the immune microenvironment in brain metastases from different solid tumorsJinling Jiang, Lihong Wu, Fei Yuan, et al.
Scientific Reports|June 14, 2018
Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancersMin Wang, Wensheng Fan, Mingxia Ye, et al.
Frontiers in Immunology|September 27, 2021
Persistent High Percentage of HLA-DR<sup>+</sup>CD38<sup>high</sup> CD8<sup>+</sup> T Cells Associated With Immune Disorder and Disease Severity of COVID-19Juan Du, Lirong Wei, Guoli Li, et al.
Pageof 13